Miebo, also known as perfluorohexyloctane ophthalmic solution, requires storage at room temperature. It should be kept between 20°C and 25°C (68°F and 77°F) [1].
What is Miebo used for?
Miebo is prescribed to treat the signs and symptoms of dry eye disease. It works by forming a lipid tear film layer that helps prevent rapid evaporation of tears from the eye's surface [1].
How does Miebo work to treat dry eye?
Miebo addresses a common cause of dry eye disease, which is tear evaporation. By creating a protective lipid layer, it reduces evaporation, thereby alleviating the associated signs and symptoms [1].
What are the potential side effects of Miebo?
The most frequently reported side effect of Miebo is blurred vision. Other potential side effects include eye irritation, reduced visual acuity, eye pain, and discharge [1].
When does Miebo's patent protection expire?
Information on specific patent expiry dates for Miebo is not readily available without consulting specialized patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which would be a resource for detailed patent timelines [2].
Who manufactures Miebo?
Miebo is manufactured by Bausch + Lomb [1].